This is a Validated Antibody Database (VAD) review about human INA, based on 10 published articles (read how Labome selects the articles), using INA antibody in all methods. It is aimed to help Labome visitors find the most suited INA antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
INA synonym: NEF5; NF-66; TXBP-1; alpha-internexin; 66 kDa neurofilament protein; alpha-Inx; neurofilament 5 (66kD); neurofilament-66, tax-binding protein

Invitrogen
mouse monoclonal (2E3)
  • immunohistochemistry - paraffin section; human; 1:800; loading ...
In order to examine the mutation spectrum of the TANK-Binding Kinase 1 gene and its associated phenotypic spectrum in patients with FTD, ALS or FTD plus ALS, Invitrogen INA antibody (Invitrogen, 2E3) was used in immunohistochemistry - paraffin section on human samples at 1:800. Hum Mutat (2017) ncbi
mouse monoclonal (2E3)
  • immunohistochemistry - paraffin section; human; 1:800; loading ...
In order to detail the neuropathological features of the anti-IgLON5 syndrome in order to diagnose patients, Invitrogen INA antibody (Invitrogen, 2E3) was used in immunohistochemistry - paraffin section on human samples at 1:800. Acta Neuropathol (2016) ncbi
mouse monoclonal (2E3)
  • immunohistochemistry - paraffin section; human; fig 3
In order to report an autopsy case of neuronal intermediate filament inclusion disease, Invitrogen INA antibody (Invitrogen, 2E3) was used in immunohistochemistry - paraffin section on human samples (fig 3). Neuropathology (2015) ncbi
mouse monoclonal (2E3)
  • western blot; human
In order to study the association of PRKAR1B mutation with a new neurodegenerative disorder, Invitrogen INA antibody (Invitrogen, 32-3600) was used in western blot on human samples . Brain (2014) ncbi
mouse monoclonal (2E3)
  • immunohistochemistry - paraffin section; human
Invitrogen INA antibody (Lab Vision, 2E3) was used in immunohistochemistry - paraffin section on human samples . Oncol Lett (2014) ncbi
mouse monoclonal (2E3)
  • immunohistochemistry; human; 1:250
In order to characterize a rare case of gliosarcoma, Invitrogen INA antibody (Labvision, 2E3) was used in immunohistochemistry on human samples at 1:250. Clin Neuropathol (2013) ncbi
mouse monoclonal (2E3)
  • immunohistochemistry - paraffin section; human; 1:300; fig 1
In order to study 4 cases of chromosome 9-linked motor neuron disease/amyotrophic lateral sclerosis, Invitrogen INA antibody (Invitrogen, 32-3600) was used in immunohistochemistry - paraffin section on human samples at 1:300 (fig 1). Neuropathology (2012) ncbi
mouse monoclonal (2E3)
  • immunohistochemistry; mouse; fig 2
In order to test if the cytoskeletal elements of olfactory sensory neuron axons may be are differentially expressed across the olfactory nerve layer, Invitrogen INA antibody (Invitrogen, 32-3600) was used in immunohistochemistry on mouse samples (fig 2). J Comp Neurol (2006) ncbi
Abcam
rabbit monoclonal (EP676Y)
  • western blot; mouse; 1:10,000; fig 7
Abcam INA antibody (Abcam, ab40758) was used in western blot on mouse samples at 1:10,000 (fig 7). Oncotarget (2016) ncbi
Novus Biologicals
rabbit polyclonal
  • western blot; mouse; 1:5000; loading ...; fig 3
In order to report the proteome of V1, V2M, and V2L from P0-enucleated, anophthalmic, and sighted mice, Novus Biologicals INA antibody (Novus Biological, NB300-139) was used in western blot on mouse samples at 1:5000 (fig 3). PLoS ONE (2016) ncbi
Articles Reviewed
  1. van der Zee J, Gijselinck I, Van Mossevelde S, Perrone F, Dillen L, Heeman B, et al. TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis. Hum Mutat. 2017;38:297-309 pubmed publisher
  2. Laramée M, Smolders K, Hu T, Bronchti G, Boire D, Arckens L. Congenital Anophthalmia and Binocular Neonatal Enucleation Differently Affect the Proteome of Primary and Secondary Visual Cortices in Mice. PLoS ONE. 2016;11:e0159320 pubmed publisher
  3. Gelpi E, Hoftberger R, Graus F, Ling H, Holton J, Dawson T, et al. Neuropathological criteria of anti-IgLON5-related tauopathy. Acta Neuropathol. 2016;132:531-43 pubmed publisher
  4. Xing R, Zhang Y, Xu H, Luo X, Chang R, Liu J, et al. Spatial memory impairment by TRPC1 depletion is ameliorated by environmental enrichment. Oncotarget. 2016;7:27855-73 pubmed publisher
  5. Inoue K, Fujimura H, Ueda K, Matsumura T, Itoh K, Sakoda S. An autopsy case of neuronal intermediate filament inclusion disease with regard to immunophenotypic and topographical analysis of the neuronal inclusions. Neuropathology. 2015;35:545-52 pubmed publisher
  6. Wong T, Chiu W, Breedveld G, Li K, Verkerk A, Hondius D, et al. PRKAR1B mutation associated with a new neurodegenerative disorder with unique pathology. Brain. 2014;137:1361-73 pubmed publisher
  7. Ishida M, Iwai M, Yoshida K, Kagotani A, Okabe H. Signet-ring cell melanoma with sentinel lymph node metastasis: A case report with immunohistochemical analysis and review of the clinicopathological features. Oncol Lett. 2014;7:65-68 pubmed
  8. Shintaku M, Yoneda H, Hirato J, Nagaishi M, Okabe H. Gliosarcoma with ependymal and PNET-like differentiation. Clin Neuropathol. 2013;32:508-14 pubmed publisher
  9. Troakes C, Maekawa S, Wijesekera L, Rogelj B, Siklós L, Bell C, et al. An MND/ALS phenotype associated with C9orf72 repeat expansion: abundant p62-positive, TDP-43-negative inclusions in cerebral cortex, hippocampus and cerebellum but without associated cognitive decline. Neuropathology. 2012;32:505-14 pubmed publisher
  10. Akins M, Greer C. Cytoskeletal organization of the developing mouse olfactory nerve layer. J Comp Neurol. 2006;494:358-67 pubmed